Search
Unicycive Therapeutics Inc
UNCYAdd to Watchlist
4.735USD
-0.075-1.56%
Market hours 09/24, 13:47（ET）
126.42MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.56%
5 Days
-0.94%
1 Month
-15.90%
6 Months
-30.06%
Year to Date
-17.94%
1 Year
+18.97%
Key Figures
4.828Open
4.960High
47.95KVolume
LossP/E TTM
2.60P/E Dynamic
--Dividend TTM
0.18%Turnover Ratio
4.810Prev. Close
4.630Low
226.31KTurnover
LossP/E Static
2.37P/B
0.00%Div Yield TTM
-86.51%ROA
8.74052wk High
0.10Volume Ratio
-37.82MNet Profit
26.70MShares
-2.2515EPS TTM
1.73Beta
-162.89%ROE
3.71052wk Low
6.86%Amplitude
100.00%Gross Margin
126.42MMarket Cap
0.24Reward/Risk
4.96%Risk Rate
More news coming soon, stay tuned...
Unicycive Therapeutics Inc's Score
-0.04vs previous score
Forecast8.22
Financial Health3.94
Technical3.67
Valuation Dimensions6.14
Institutional Confidence3.00
Risk Assessment3.04
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Unicycive Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.06/-0.34
Revenue / Forecast
--/0.00
Unicycive Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolUNCY
Number of employees22
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Vivo Capital, LLC | 6.70% |
| Millennium Management LLC | 4.39% |
| Octagon Capital Advisors LP | 3.75% |
| Nantahala Capital Management, LLC | 3.52% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 16.98% |
| Venture Capital | 8.61% |
| Investment Advisor | 4.70% |
| Individual Investor | 2.36% |
Related Instruments
+3.11%
+0.75%
-0.46%
+0.07%
+0.32%
+1.33%
-0.30%
-0.37%
+0.30%
+0.99%
+0.88%
-0.38%
-0.11%
-0.06%
-1.68%
-1.10%
+1.16%
+0.85%
-1.33%
+1.68%Popular Instruments
51286.400
-203.600 (-0.40%)
30396.600
-81.300 (-0.27%)
7694.000
-13.000 (-0.17%)
14266.000
-156.000 (-1.08%)
65743.000
-386.000 (-0.58%)
6304.200
+14.200 (+0.23%)
95.283
+2.793 (+3.02%)
336.740
-0.280 (-0.08%)
223.980
-1.530 (-0.68%)
4259.580
-26.660 (-0.62%)
FAQs
What is the current price of Unicycive Therapeutics Inc (UNCY)?
The current price of Unicycive Therapeutics Inc (UNCY) is 4.81.
What is the symbol of Unicycive Therapeutics Inc?
The ticker symbol of Unicycive Therapeutics Inc is UNCY.
What is the 52-week high of Unicycive Therapeutics Inc?
The 52-week high of Unicycive Therapeutics Inc is 8.74.
What is the 52-week low of Unicycive Therapeutics Inc?
The 52-week low of Unicycive Therapeutics Inc is 3.71.
What is the market capitalization of Unicycive Therapeutics Inc?
The market capitalization of Unicycive Therapeutics Inc is 128.43M.
Is Unicycive Therapeutics Inc (UNCY) currently rated as Buy, Hold, or Sell?
According to analysts, Unicycive Therapeutics Inc (UNCY) has an overall rating of Buy, with a price target of 28.22.
What is the Earnings Per Share (EPS TTM) of Unicycive Therapeutics Inc (UNCY)?
The Earnings Per Share (EPS TTM) of Unicycive Therapeutics Inc (UNCY) is -2.25.